LIQUIDAMBAR STYRACIFLUA POLLEN: 21 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
21
Total FAERS Reports
0
Deaths Reported
0
Hospitalizations
21
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20140122 · Latest Report: 20231016
What Are the Most Common LIQUIDAMBAR STYRACIFLUA POLLEN Side Effects?
#1 Most Reported
Anaphylactic reaction
7 reports (33.3%)
#2 Most Reported
Urticaria
4 reports (19.0%)
#3 Most Reported
Throat tightness
3 reports (14.3%)
All LIQUIDAMBAR STYRACIFLUA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 7 | 33.3% | 0 | 0 |
Who Reports LIQUIDAMBAR STYRACIFLUA POLLEN Side Effects? Age & Gender Data
Gender: 84.2% female, 15.8% male. Average age: 35.4 years. Most reports from: US. View detailed demographics →
Is LIQUIDAMBAR STYRACIFLUA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 0 |
| 2016 | 6 | 0 | 0 |
| 2017 | 2 | 0 | 0 |
| 2018 | 1 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 2 | 0 | 0 |
| 2022 | 2 | 0 | 0 |
| 2023 | 3 | 0 | 0 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for LIQUIDAMBAR STYRACIFLUA POLLEN
Official prescribing information from the FDA-approved drug label.